Setting

Global Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region: Trend Forecast and Growth Opportunity

Published: 26 Aug 2020 | Report Code: 10247649 | Pages: 182

Global antibiotics market will reach $63.99 billion by 2030, growing by 3.5% annually over 2020-2030 driven by rising incidences of bacterial infection, growing awareness and need for new drugs and treatment amid the COVID-19 epidemic. Highlighted with 86 tables and 93 figures, this 182-page report “Global Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region. Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Cephalosporin • Penicillin • Macrolides • Fluoroquinolones • Quinolones • Monobactam • Aminoglycosides • Carbapenem • Other Drug Classes Based on Action Mechanism, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Cell Wall Synthesis Inhibitors • Mycolic Acid Inhibitors • RNA Synthesis Inhibitors • DNA Synthesis Inhibitors • Protein Synthesis Inhibitors • Other Mechanisms Based on Drug Origin, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Natural Antibiotics • Semi-synthetic Antibiotics • Synthetic Antibiotics Based on Activity Spectrum, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Broad-spectrum Antibiotics • Narrow-spectrum Antibiotics Based on Route of Administration, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Oral Administration • Intravenous Administration • Other Administration Routes Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Brand Antibiotics • Generic Antibiotics Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • RoW (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Class, Drug Origin, and Route of Administration over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global antibiotics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories Astellas Pharma AstraZeneca Plc Bayer AG Bristol Myers Squibb Company Cipla Inc. Dr. Reddy’s Laboratories Ltd. Eli Lilly and Company F. Hoffmann-La Roche Ltd. Gilead Sciences, Inc. GlaxoSmithKline plc. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) Mayne Pharma Group Ltd. MELINTA THERAPEUTICS, INC. Merck KGaA Novartis AG Pfizer Inc. Sanofi Sun Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	10
1.1 Industry Definition and Research Scope	10
1.1.1 Industry Definition	10
1.1.2 Research Scope	11
1.2 Research Methodology	14
1.2.1 Overview of Market Research Methodology	14
1.2.2 Market Assumption	15
1.2.3 Secondary Data	15
1.2.4 Primary Data	15
1.2.5 Data Filtration and Model Design	17
1.2.6 Market Size/Share Estimation	18
1.2.7 Research Limitations	19
1.3 Executive Summary	20
2 Market Overview and Dynamics	23
2.1 Market Size and Forecast	23
2.1.1 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of Global Market by Drug Class	41
3.1 Market Overview by Drug Class	41
3.2 Cephalosporin	43
3.3 Penicillin	44
3.4 Macrolides	45
3.5 Fluoroquinolones	46
3.6 Quinolones	47
3.7 Monobactam	48
3.8 Aminoglycosides	49
3.9 Carbapenem	50
3.10 Other Drug Classes	51
4 Segmentation of Global Market by Action Mechanism	52
4.1 Market Overview by Action Mechanism	52
4.2 Cell Wall Synthesis Inhibitors	54
4.3 Mycolic Acid Inhibitors	55
4.4 RNA Synthesis Inhibitors	56
4.5 DNA Synthesis Inhibitors	57
4.6 Protein Synthesis Inhibitors	58
4.7 Other Mechanisms	59
5 Segmentation of Global Market by Drug Origin	60
5.1 Market Overview by Drug Origin	60
5.2 Natural Antibiotics	62
5.3 Semi-synthetic Antibiotics	63
5.4 Synthetic Antibiotics	64
6 Segmentation of Global Market by Activity Spectrum	65
6.1 Market Overview by Activity Spectrum	65
6.2 Broad-spectrum Antibiotics	67
6.3 Narrow-spectrum Antibiotics	68
7 Segmentation of Global Market by Route of Administration	69
7.1 Market Overview by Route of Administration	69
7.2 Oral Administration	71
7.3 Intravenous Administration	72
7.4 Other Administration Routes	73
8 Segmentation of Global Market by Drug Type	74
8.1 Market Overview by Drug Type	74
8.2 Brand Antibiotics	76
8.3 Generic Antibiotics	77
9 Segmentation of Global Market by Region	78
9.1 Geographic Market Overview 2019-2030	78
9.2 North America Market 2019-2030 by Country	84
9.2.1 Overview of North America Market	84
9.2.2 U.S.	88
9.2.3 Canada	92
9.2.4 Mexico	94
9.3 European Market 2019-2030 by Country	96
9.3.1 Overview of European Market	96
9.3.2 Germany	100
9.3.3 UK	102
9.3.4 France	104
9.3.5 Spain	106
9.3.6 Italy	108
9.3.7 Russia	110
9.3.8 Rest of European Market	112
9.4 Asia-Pacific Market 2019-2030 by Country	114
9.4.1 Overview of Asia-Pacific Market	114
9.4.2 Japan	118
9.4.3 China	121
9.4.4 Australia	123
9.4.5 India	125
9.4.6 South Korea	127
9.4.7 Rest of APAC Region	129
9.5 South America Market 2019-2030 by Country	131
9.5.1 Argentina	134
9.5.2 Brazil	136
9.5.3 Chile	138
9.5.4 Rest of South America Market	140
9.6 MEA Market 2019-2030 by Country	141
9.6.1 UAE	144
9.6.2 Saudi Arabia	146
9.6.3 South Africa	148
9.6.4 Other National Markets	150
10 Competitive Landscape	151
10.1 Overview of Key Vendors	151
10.2 New Product Launch, Partnership, Investment, and M&A	155
10.3 Company Profiles	156
Abbott Laboratories	156
Astellas Pharma	158
AstraZeneca Plc	159
Bayer AG	160
Bristol Myers Squibb Company	161
Cipla Inc.	162
Dr. Reddy’s Laboratories Ltd.	163
Eli Lilly and Company	164
F. Hoffmann-La Roche Ltd.	165
Gilead Sciences, Inc.	166
GlaxoSmithKline plc.	167
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)	168
Mayne Pharma Group Ltd.	169
MELINTA THERAPEUTICS, INC.	170
Merck KGaA	171
Novartis AG	172
Pfizer Inc.	173
Sanofi	174
Sun Pharmaceutical Industries Ltd.	175
11 Investing in Global Market: Risk Assessment and Management	176
11.1 Risk Evaluation of Global Market	176
11.2 Critical Success Factors (CSFs)	179
Related Reports and Products	182
List Of Tables

Table 1.  Snapshot of Global Antibiotics Market, 2019-2030	21
Table 2.  Main Product Trends and Market Opportunities in Global Antibiotics Market	33
Table 3. Global Antibiotics Market by Drug Class, 2019-2030, $ mn	41
Table 4. Global Antibiotics Market by Action Mechanism, 2019-2030, $ mn	52
Table 5. Global Antibiotics Market by Drug Origin, 2019-2030, $ mn	60
Table 6. Global Antibiotics Market by Activity Spectrum, 2019-2030, $ mn	65
Table 7. Global Antibiotics Market by Route of Administration, 2019-2030, $ mn	69
Table 8. Global Antibiotics Market by Drug Type, 2019-2030, $ bn	74
Table 9. Global Antibiotics Market by Region, 2019-2030, $ bn	79
Table 10. Total Health Expenditure per capita in PPP International U.S. Dollars by Country	81
Table 11.  Leading National Antibiotics Market, 2019 and 2030, $ bn	83
Table 12. North America Antibiotics Market by Country, 2019-2030, $ bn	86
Table 13. U.S. Antibiotics Market by Drug Class, 2019-2030, $ mn	90
Table 14. U.S. Antibiotics Market by Drug Origin, 2019-2030, $ mn	90
Table 15. U.S. Antibiotics Market by Route of Administration, 2019-2030, $ mn	90
Table 16. Canada Antibiotics Market by Drug Class, 2019-2030, $ mn	93
Table 17. Canada Antibiotics Market by Drug Origin, 2019-2030, $ mn	93
Table 18. Canada Antibiotics Market by Route of Administration, 2019-2030, $ mn	93
Table 19. Mexico Antibiotics Market by Drug Class, 2019-2030, $ mn	95
Table 20. Mexico Antibiotics Market by Drug Origin, 2019-2030, $ mn	95
Table 21. Mexico Antibiotics Market by Route of Administration, 2019-2030, $ mn	95
Table 22. Europe Antibiotics Market by Country, 2019-2030, $ bn	99
Table 23. Germany Antibiotics Market by Drug Class, 2019-2030, $ mn	101
Table 24. Germany Antibiotics Market by Drug Origin, 2019-2030, $ mn	101
Table 25. Germany Antibiotics Market by Route of Administration, 2019-2030, $ mn	101
Table 26. UK Antibiotics Market by Drug Class, 2019-2030, $ mn	103
Table 27. UK Antibiotics Market by Drug Origin, 2019-2030, $ mn	103
Table 28. UK Antibiotics Market by Route of Administration, 2019-2030, $ mn	103
Table 29. France Antibiotics Market by Drug Class, 2019-2030, $ mn	105
Table 30. France Antibiotics Market by Drug Origin, 2019-2030, $ mn	105
Table 31. France Antibiotics Market by Route of Administration, 2019-2030, $ mn	105
Table 32. Spain Antibiotics Market by Drug Class, 2019-2030, $ mn	107
Table 33. Spain Antibiotics Market by Drug Origin, 2019-2030, $ mn	107
Table 34. Spain Antibiotics Market by Route of Administration, 2019-2030, $ mn	107
Table 35. Italy Antibiotics Market by Drug Class, 2019-2030, $ mn	109
Table 36. Italy Antibiotics Market by Drug Origin, 2019-2030, $ mn	109
Table 37. Italy Antibiotics Market by Route of Administration, 2019-2030, $ mn	109
Table 38. Russia Antibiotics Market by Drug Class, 2019-2030, $ mn	111
Table 39. Russia Antibiotics Market by Drug Origin, 2019-2030, $ mn	111
Table 40. Russia Antibiotics Market by Route of Administration, 2019-2030, $ mn	111
Table 41. Antibiotics Market in Rest of Europe by Country, 2019-2030, $ bn	113
Table 42. APAC Antibiotics Market by Country, 2019-2030, $ bn	116
Table 43. Japan Antibiotics Market by Drug Class, 2019-2030, $ mn	120
Table 44. Japan Antibiotics Market by Drug Origin, 2019-2030, $ mn	120
Table 45. Japan Antibiotics Market by Route of Administration, 2019-2030, $ mn	120
Table 46. China Antibiotics Market by Drug Class, 2019-2030, $ mn	122
Table 47. China Antibiotics Market by Drug Origin, 2019-2030, $ mn	122
Table 48. China Antibiotics Market by Route of Administration, 2019-2030, $ mn	122
Table 49. Australia Antibiotics Market by Drug Class, 2019-2030, $ mn	124
Table 50. Australia Antibiotics Market by Drug Origin, 2019-2030, $ mn	124
Table 51. Australia Antibiotics Market by Route of Administration, 2019-2030, $ mn	124
Table 52. India Antibiotics Market by Drug Class, 2019-2030, $ mn	126
Table 53. India Antibiotics Market by Drug Origin, 2019-2030, $ mn	126
Table 54. India Antibiotics Market by Route of Administration, 2019-2030, $ mn	126
Table 55. South Korea Antibiotics Market by Drug Class, 2019-2030, $ mn	128
Table 56. South Korea Antibiotics Market by Drug Origin, 2019-2030, $ mn	128
Table 57. South Korea Antibiotics Market by Route of Administration, 2019-2030, $ mn	128
Table 58. Antibiotics Market in Rest of APAC by Country, 2019-2030, $ bn	130
Table 59. South America Antibiotics Market by Country, 2019-2030, $ bn	133
Table 60. Argentina Antibiotics Market by Drug Class, 2019-2030, $ mn	135
Table 61. Argentina Antibiotics Market by Drug Origin, 2019-2030, $ mn	135
Table 62. Argentina Antibiotics Market by Route of Administration, 2019-2030, $ mn	135
Table 63. Brazil Antibiotics Market by Drug Class, 2019-2030, $ mn	137
Table 64. Brazil Antibiotics Market by Drug Origin, 2019-2030, $ mn	137
Table 65. Brazil Antibiotics Market by Route of Administration, 2019-2030, $ mn	137
Table 66. Chile Antibiotics Market by Drug Class, 2019-2030, $ mn	139
Table 67. Chile Antibiotics Market by Drug Origin, 2019-2030, $ mn	139
Table 68. Chile Antibiotics Market by Route of Administration, 2019-2030, $ mn	139
Table 69. MEA Antibiotics Market by Country, 2019-2030, $ bn	143
Table 70. UAE Antibiotics Market by Drug Class, 2019-2030, $ mn	145
Table 71. UAE Antibiotics Market by Drug Origin, 2019-2030, $ mn	145
Table 72. UAE Antibiotics Market by Route of Administration, 2019-2030, $ mn	145
Table 73. Saudi Arabia Antibiotics Market by Drug Class, 2019-2030, $ mn	147
Table 74. Saudi Arabia Antibiotics Market by Drug Origin, 2019-2030, $ mn	147
Table 75. Saudi Arabia Antibiotics Market by Route of Administration, 2019-2030, $ mn	147
Table 76. South Africa Antibiotics Market by Drug Class, 2019-2030, $ mn	149
Table 77. South Africa Antibiotics Market by Drug Origin, 2019-2030, $ mn	149
Table 78. South Africa Antibiotics Market by Route of Administration, 2019-2030, $ mn	149
Table 79. Breakdown of Global Market by Key Vendor, 2019, %	153
Table 80. Abbott Laboratories: Company Snapshot	156
Table 81. Abbott Laboratories: Business Segmentation	156
Table 82. Abbott Laboratories: Product Portfolio	157
Table 83. Abbott Laboratories: Revenue, 2016-2018, $ mn	157
Table 84. Abbott Laboratories: Recent Developments	157
Table 85.  Risk Evaluation for Investing in Global Market, 2019-2030	177
Table 86. Critical Success Factors and Key Takeaways	180
List Of Figures

Figure 1. Research Method Flow Chart	14
Figure 2. Breakdown of Primary Research	16
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	18
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	20
Figure 5. Global Antibiotics Market, 2019-2030, $ mn	23
Figure 6. Impact of COVID-19 on Business	24
Figure 7. Primary Drivers and Impact Factors of Global Antibiotics Market	26
Figure 8. GDP per capita in the World, 1960-2018, $ thousand	29
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million	29
Figure 10. Primary Restraints and Impact Factors of Global Antibiotics Market	30
Figure 11. Investment Opportunity Analysis	34
Figure 12. Porter’s Fiver Forces Analysis of Global Antibiotics Market	37
Figure 13. Breakdown of Global Antibiotics Market by Drug Class, 2019-2030, % of Revenue	42
Figure 14. Global Addressable Market Cap in 2020-2030 by Drug Class, Value ($ mn) and Share (%)	42
Figure 15. Global Antibiotics Market: Cephalosporin, 2019-2030, $ mn	43
Figure 16. Global Antibiotics Market: Penicillin, 2019-2030, $ mn	44
Figure 17. Global Antibiotics Market: Macrolides, 2019-2030, $ mn	45
Figure 18. Global Antibiotics Market: Fluoroquinolones, 2019-2030, $ mn	46
Figure 19. Global Antibiotics Market: Quinolones, 2019-2030, $ mn	47
Figure 20. Global Antibiotics Market: Monobactam, 2019-2030, $ mn	48
Figure 21. Global Antibiotics Market: Aminoglycosides, 2019-2030, $ mn	49
Figure 22. Global Antibiotics Market: Carbapenem, 2019-2030, $ mn	50
Figure 23. Global Antibiotics Market: Other Drug Classes, 2019-2030, $ mn	51
Figure 24. Breakdown of Global Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue	53
Figure 25. Global Addressable Market Cap in 2020-2030 by Action Mechanism, Value ($ mn) and Share (%)	53
Figure 26. Global Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, $ mn	54
Figure 27. Global Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, $ mn	55
Figure 28. Global Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, $ mn	56
Figure 29. Global Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, $ mn	57
Figure 30. Global Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, $ mn	58
Figure 31. Global Antibiotics Market: Other Mechanisms, 2019-2030, $ mn	59
Figure 32. Breakdown of Global Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue	61
Figure 33. Global Addressable Market Cap in 2020-2030 by Drug Origin, Value ($ mn) and Share (%)	61
Figure 34. Global Antibiotics Market: Natural Antibiotics, 2019-2030, $ mn	62
Figure 35. Global Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, $ mn	63
Figure 36. Global Antibiotics Market: Synthetic Antibiotics, 2019-2030, $ mn	64
Figure 37. Breakdown of Global Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue	66
Figure 38. Global Addressable Market Cap in 2020-2030 by Activity Spectrum, Value ($ mn) and Share (%)	66
Figure 39. Global Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, $ mn	67
Figure 40. Global Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, $ mn	68
Figure 41. Breakdown of Global Antibiotics Market by Route of Administration, 2019-2030, % of Revenue	70
Figure 42. Global Addressable Market Cap in 2020-2030 by Route of Administration, Value ($ mn) and Share (%)	70
Figure 43. Global Antibiotics Market: Oral Administration, 2019-2030, $ mn	71
Figure 44. Global Antibiotics Market: Intravenous Administration, 2019-2030, $ mn	72
Figure 45. Global Antibiotics Market: Other Administration Routes, 2019-2030, $ mn	73
Figure 46. Breakdown of Global Antibiotics Market by Drug Type, 2019-2030, % of Revenue	74
Figure 47. Global Addressable Market Cap in 2020-2030 by Drug Type, Value ($ bn) and Share (%)	75
Figure 48. Global Antibiotics Market: Brand Antibiotics, 2019-2030, $ bn	76
Figure 49. Global Antibiotics Market: Generic Antibiotics, 2019-2030, $ bn	77
Figure 50.  Global Market Snapshot by Region	78
Figure 51.  Geographic Spread of Worldwide Antibiotics Market, 2019-2030, % of Sales Revenue	79
Figure 52. Global Addressable Market Cap in 2020-2030 by Region, Value ($ bn) and Share (%)	80
Figure 53. Health Spending as a Share of GDP by Country, 2015 and 2030	82
Figure 54.  North American Antibiotics Market, 2019-2030, $ bn	85
Figure 55. Breakdown of North America Antibiotics Market by Country, 2019 and 2030, % of Revenue	86
Figure 56. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)	87
Figure 57. U.S. Antibiotics Market, 2019-2030, $ bn	89
Figure 58. Rising Incidence of Infectious Disease in U.S.	89
Figure 59. Canada Antibiotics Market, 2019-2030, $ bn	92
Figure 60.  Antibiotics Market in Mexico, 2015-2030, $ bn	94
Figure 61.  European Antibiotics Market, 2019-2030, $ bn	97
Figure 62. Breakdown of European Antibiotics Market by Country, 2019 and 2030, % of Revenue	98
Figure 63. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)	99
Figure 64.  Antibiotics Market in Germany, 2019-2030, $ bn	100
Figure 65.  Antibiotics Market in UK, 2019-2030, $ bn	102
Figure 66.  Antibiotics Market in France, 2019-2030, $ bn	104
Figure 67.  Antibiotics Market in Spain, 2019-2030, $ bn	106
Figure 68.  Antibiotics Market in Italy, 2019-2030, $ bn	108
Figure 69.  Antibiotics Market in Russia, 2019-2030, $ bn	110
Figure 70.  Antibiotics Market in Rest of Europe, 2019-2030, $ bn	112
Figure 71. Asia-Pacific Antibiotics Market, 2019-2030, $ bn	115
Figure 72. Breakdown of APAC Antibiotics Market by Country, 2019 and 2030, % of Revenue	115
Figure 73. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)	117
Figure 74.  Antibiotics Market in Japan, 2019-2030, $ bn	119
Figure 75.  Antibiotics Market in China, 2019-2030, $ bn	121
Figure 76.  Antibiotics Market in Australia, 2019-2030, $ bn	123
Figure 77.  Antibiotics Market in India, 2019-2030, $ bn	125
Figure 78.  Antibiotics Market in South Korea, 2019-2030, $ bn	127
Figure 79.  Antibiotics Market in Rest of APAC, 2019-2030, $ bn	129
Figure 80. South America Antibiotics Market, 2019-2030, $ bn	132
Figure 81. Breakdown of South America Antibiotics Market by Country, 2019 and 2030, % of Revenue	132
Figure 82. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)	133
Figure 83.  Antibiotics Market in Argentina, 2019-2030, $ bn	134
Figure 84.  Antibiotics Market in Brazil, 2019-2030, $ bn	136
Figure 85.  Antibiotics Market in Chile, 2019-2030, $ bn	138
Figure 86.  Antibiotics Market in Rest of South America, 2019-2030, $ bn	140
Figure 87. Antibiotics Market in Middle East and Africa (MEA), 2019-2030, $ bn	142
Figure 88. Breakdown of MEA Antibiotics Market by Country, 2019 and 2030, % of Revenue	142
Figure 89. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)	143
Figure 90.  Antibiotics Market in UAE, 2019-2030, $ bn	144
Figure 91.  Antibiotics Market in Saudi Arabia, 2019-2030, $ bn	146
Figure 92.  Antibiotics Market in South Africa, 2019-2030, $ bn	148
Figure 93. Growth Stage of Global Antibiotics Industry over the Forecast Period	151
Key Players (this may not be a complete list and extra companies can be added upon request): 
Abbott Laboratories	
Astellas Pharma	
AstraZeneca Plc	
Bayer AG	
Bristol Myers Squibb Company	
Cipla Inc.	
Dr. Reddy’s Laboratories Ltd.	
Eli Lilly and Company	
F. Hoffmann-La Roche Ltd.	
Gilead Sciences, Inc.	
GlaxoSmithKline plc.	
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)	
Mayne Pharma Group Ltd.	
MELINTA THERAPEUTICS, INC.	
Merck KGaA	
Novartis AG	
Pfizer Inc.	
Sanofi	
Sun Pharmaceutical Industries Ltd.